All Stories

  1. Hallmarks of Cancer Affected by the MIF Cytokine Family
  2. The Trypanosomal Transferrin Receptor of Trypanosoma Brucei—A Review
  3. Novel half-life extended anti-MIF nanobodies protect against endotoxic shock
  4. The anuran skin peptide bradykinin mediates its own absorption across epithelial barriers of the digestive tract
  5. African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System
  6. MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset
  7. Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis
  8. Reprint of: The non-mammalian MIF superfamily
  9. African Trypanosomes Undermine Humoral Responses and Vaccine Development: Link with Inflammatory Responses?
  10. The non-mammalian MIF superfamily
  11. Early Immunological Responses Upon Tsetse Fly–Mediated Trypanosome Inoculation
  12. Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to Pathogenicity
  13. An Anti-proteome Nanobody Library Approach Yields a Specific Immunoassay for Trypanosoma congolense Diagnosis Targeting Glycosomal Aldolase
  14. The Possible Role of Staphylococcus epidermidis LPxTG Surface Protein SesC in Biofilm Formation
  15. E-cadherin expression in macrophages dampens their inflammatory responsiveness in vitro, but does not modulate M2-regulated pathologies in vivo
  16. NK-, NKT- and CD8-Derived IFNγ Drives Myeloid Cell Activation and Erythrophagocytosis, Resulting in Trypanosomosis-Associated Acute Anemia
  17. Development of a pHrodo-Based Assay for the Assessment of In Vitro and In Vivo Erythrophagocytosis during Experimental Trypanosomosis
  18. Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm
  19. Murine Liver Myeloid Cell Isolation Protocol
  20. Iron Homeostasis andTrypanosoma bruceiAssociated Immunopathogenicity Development: A Battle/Quest for Iron
  21. Generation of a Nanobody Targeting the Paraflagellar Rod Protein of Trypanosomes
  22. MIF Contributes to Trypanosoma brucei Associated Immunopathogenicity Development
  23. Antibody-mediated control ofTrypanosoma vivaxinfection fails in the absence of tumour necrosis factor
  24. Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages
  25. Low Structural Variation in the Host-Defense Peptide Repertoire of the Dwarf Clawed Frog Hymenochirus boettgeri (Pipidae)
  26. African Trypanosomiasis as Paradigm for Involvement of the Mononuclear Phagocyte System in Pathogenicity During Parasite Infection
  27. A Trypanosoma brucei Kinesin Heavy Chain Promotes Parasite Growth by Triggering Host Arginase Activity
  28. Origin and Functional Diversification of an Amphibian Defense Peptide Arsenal
  29. Characterization of central macrophages in Anemia of Inflammation (AI): African trypanosomiasis as a model system
  30. Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
  31. Tsetse Salivary Gland Proteins 1 and 2 Are High Affinity Nucleic Acid Binding Proteins with Residual Nuclease Activity
  32. Vaccination with SesC Decreases Staphylococcus epidermidis Biofilm Formation
  33. Expression and extracellular release of a functional anti-trypanosome Nanobody® in Sodalis glossinidius, a bacterial symbiont of the tsetse fly
  34. Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses
  35. IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member inTrypanosoma congolenseinfection-resistant C57BL/6 mice
  36. High Affinity Nanobodies against the Trypanosome brucei VSG Are Potent Trypanolytic Agents that Block Endocytosis
  37. Lack of galectin-3 alleviates trypanosomiasis-associated anemia of inflammation
  38. Tip-DC Development during Parasitic Infection Is Regulated by IL-10 and Requires CCL2/CCR2, IFN-γ and MyD88 Signaling
  39. Current status of vaccination against African trypanosomiasis
  40. Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis
  41. The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches
  42. Identification of a Parasitic Immunomodulatory Protein Triggering the Development of Suppressive M1 Macrophages during African Trypanosomiasis
  43. Differentiation, activation and function of CD11b+Ly6C+ TNF/iNOS-producing dendritic cells during parasitic infection
  44. Understanding the role of monocytic cells in liver inflammation using parasite infection as a model
  45. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice
  46. Role of iron homeostasis in trypanosomiasis-associated anemia
  47. Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens
  48. A Glycosylphosphatidylinositol-Based Treatment Alleviates Trypanosomiasis-Associated Immunopathology
  49. African trypanosomosis: From immune escape and immunopathology to immune intervention
  50. Traitement expérimental de la trypanosomiase africaine par le facteur trypanolytique humain combiné à un nanocorps
  51. Evidence for proteins involved in prophenoloxidase cascade Eisenia fetida earthworms
  52. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
  53. Antigen Binding and Solubility Effects upon the Veneering of a Camel VHH in Framework-2 to Mimic a VH
  54. P75 Tumor Necrosis Factor–Receptor Shedding Occurs as a Protective Host Response during African Trypanosomiasis
  55. Efficient Targeting of Conserved Cryptic Epitopes of Infectious Agents by Single Domain Antibodies
  56. VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology
  57. Distinct Carbohydrate Recognition Domains of an Invertebrate Defense Molecule Recognize Gram-negative and Gram-positive Bacteria
  58. Attenuation ofTrypanosoma bruceiIs Associated with Reduced Immunosuppression and Concomitant Production of Th2 Lymphokines
  59. Detection of clinically relevant antibodies pretransplant and posttransplant with PRA-STAT